# Grace Therapeutics, Inc.: Form 8-K, filed Apr 30, 2020

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2020-04-30
- Accepted by EDGAR: Apr 30, 2020, 16:22 ET
- Period: 2020-04-30
- Accession: 0001171843-20-003135
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000117184320003135/f8k_043020.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000117184320003135/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000117184320003135/f8k_043020.htm

Filed Apr 30, 2020.
Source: SEC EDGAR, the filing index for accession 0001171843-20-003135. Last ingested by Listed: Nov 14, 2026, 23:10 ET. No prices; not investment advice.
